Diebold Nixdorf, Incorporated (NYSE:DBD) Major Shareholder Millstreet Capital Management Sells 457,715 Shares

Diebold Nixdorf, Incorporated (NYSE:DBDGet Free Report) major shareholder Millstreet Capital Management sold 457,715 shares of the company’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $33.95, for a total transaction of $15,539,424.25. Following the sale, the insider now owns 6,477,361 shares of the company’s stock, valued at $219,906,405.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Diebold Nixdorf Price Performance

DBD stock opened at $34.80 on Friday. The firm has a 50-day moving average of $32.52 and a 200 day moving average of $26.03. The company has a debt-to-equity ratio of 1.16, a current ratio of 1.52 and a quick ratio of 1.10. Diebold Nixdorf, Incorporated has a 1 year low of $16.50 and a 1 year high of $35.94.

Diebold Nixdorf (NYSE:DBDGet Free Report) last announced its earnings results on Wednesday, February 14th. The technology company reported $3.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $1.63. The firm had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.02 billion. As a group, equities research analysts anticipate that Diebold Nixdorf, Incorporated will post 3.94 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of DBD. Russell Investments Group Ltd. increased its stake in Diebold Nixdorf by 3.9% during the 4th quarter. Russell Investments Group Ltd. now owns 31,579 shares of the technology company’s stock valued at $914,000 after purchasing an additional 1,178 shares in the last quarter. FMR LLC bought a new stake in shares of Diebold Nixdorf in the 3rd quarter worth $26,000. Tower Research Capital LLC TRC bought a new stake in Diebold Nixdorf in the 4th quarter worth about $46,000. JPMorgan Chase & Co. increased its holdings in Diebold Nixdorf by 3.7% in the 2nd quarter. JPMorgan Chase & Co. now owns 65,264 shares of the technology company’s stock worth $149,000 after buying an additional 2,330 shares in the last quarter. Finally, MetLife Investment Management LLC grew its stake in shares of Diebold Nixdorf by 14.9% in the first quarter. MetLife Investment Management LLC now owns 28,775 shares of the technology company’s stock worth $194,000 after acquiring an additional 3,730 shares during the period.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on DBD. Wedbush restated a “neutral” rating and set a $25.00 target price on shares of Diebold Nixdorf in a report on Monday, February 12th. StockNews.com raised shares of Diebold Nixdorf from a “hold” rating to a “buy” rating in a research report on Friday.

Check Out Our Latest Stock Report on Diebold Nixdorf

Diebold Nixdorf Company Profile

(Get Free Report)

Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide. It operates through two segments, Banking and Retail. The company offers cash recyclers and dispensers, intelligent deposit terminals, teller automation tools, and kiosk technologies, as well as physical security solutions; and front-end applications for consumer connection points and back-end platforms that manage channel transactions, operations and integration, and facilitate omnichannel transactions, endpoint monitoring, remote asset management, customer marketing, merchandise management, and analytics.

Further Reading

Insider Buying and Selling by Quarter for Diebold Nixdorf (NYSE:DBD)

Receive News & Ratings for Diebold Nixdorf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diebold Nixdorf and related companies with MarketBeat.com's FREE daily email newsletter.